Moderna, Novavax among biotechs working on novel virus -- but vaccine at least a year out
At least four groups have started to develop vaccines to protect against the 2019 Novel Coronavirus (2019-nCoV) that was first detected in Wuhan, China.
Among companies working on a vaccine, Moderna Inc. (NASDAQ:MRNA) has partnered with NIH, while Novavax Inc. (NASDAQ:NVAX) shares rose sharply Tuesday on its development plans.
It will, however, take at least a year and likely close to two years for a vaccine to be available on an emergency-use basis.
There are close to 300 confirmed cases of 2019-nCoV in China including at least four deaths, according